BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21529437)

  • 1. Safety of recombinant human growth hormone in treating children with growth hormone deficiency and idiopathic short stature.
    Chang S; Hui P
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Apr; 33(2):123-6. PubMed ID: 21529437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of growth hormone treatment of children with idiopathic short stature: the US experience.
    Allen DB
    Horm Res Paediatr; 2011; 76 Suppl 3():45-7. PubMed ID: 21912165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database.
    Darendeliler F; Karagiannis G; Wilton P
    Horm Res; 2007; 68 Suppl 5():41-7. PubMed ID: 18174706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and humanistic aspects of growth hormone deficiency and growth-related disorders.
    Rogol AD
    Am J Manag Care; 2011 Dec; 17 Suppl 18():eS4-10. PubMed ID: 22590765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Debate on the use of growth hormone in the treatment of children with idiopathic short stature (ISS) (Pro and Con).
    Rogol AD; Wit JM
    Pediatr Endocrinol Rev; 2007 Mar; 4(3):226-7. PubMed ID: 17551485
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of growth hormone in children.
    Hindmarsh PC; Dattani MT
    Nat Clin Pract Endocrinol Metab; 2006 May; 2(5):260-8. PubMed ID: 16932297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of growth hormone on craniofacial growth.
    Funatsu M; Sato K; Mitani H
    Angle Orthod; 2006 Nov; 76(6):970-7. PubMed ID: 17090153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic benefits of growth hormone therapy in idiopathic short stature.
    Dahlgren J
    Horm Res Paediatr; 2011; 76 Suppl 3():56-8. PubMed ID: 21912170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Debate: idiopathic short stature should be treated with growth hormone.
    Ambler GR; Fairchild J; Wilkinson DJ
    J Paediatr Child Health; 2013 Mar; 49(3):165-9. PubMed ID: 22582941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of the recombinant human growth hormone Omnitrope® in the treatment of Spanish growth hormone deficient children: results of a phase III study.
    López-Siguero J; Borrás Pérez MV; Balser S; Khan-Boluki J
    Adv Ther; 2011 Oct; 28(10):879-93. PubMed ID: 21948492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of catch-up growth from orthodontic treatment and supplemental growth hormone therapy by using Z-scores.
    Tsuboi Y; Yamashiro T; Ando R; Takano-Yamamoto T
    Am J Orthod Dentofacial Orthop; 2008 Mar; 133(3):450-8. PubMed ID: 18331947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone in children with idiopathic short stature.
    Albertsson-Wikland K
    BMJ; 2011 Mar; 342():d1248. PubMed ID: 21402668
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of second somatonorm treatment in idiopathic growth hormone deficiency dwarfism].
    Bao X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Dec; 13(6):443-6. PubMed ID: 1838961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human growth hormone in the treatment of patients with cystic fibrosis.
    Phung OJ; Coleman CI; Baker EL; Scholle JM; Girotto JE; Makanji SS; Chen WT; Talati R; Kluger J; White CM
    Pediatrics; 2010 Nov; 126(5):e1211-26. PubMed ID: 20921071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of adult growth hormone deficiency.
    Johannsson G
    Endocrinol Metab Clin North Am; 2007 Mar; 36(1):203-20. PubMed ID: 17336741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GH in idiopathic short stature. Is treating a poorly defined illness ethical?
    Caldwell PJ
    BMJ; 2011 Apr; 342():d2144. PubMed ID: 21467110
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short term growth hormone therapy in adult growth hormone deficiency.
    Dutta P; Bhansali A; Ajith Kumar BV; Sharma R; Jaggi S; Bhadada S
    J Assoc Physicians India; 2010 Nov; 58():670-3. PubMed ID: 21510459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of recombinant Human Growth Hormone (rHGH)].
    Calzada-León R
    Rev Med Inst Mex Seguro Soc; 2017; 55(2):196-213. PubMed ID: 28296370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.